Anastasios Papadopoulos
Medical Oncologist
Dr. Anastasios Papadopoulos was born 1983 in Tripoli, Greece and grew up in Patra, Greece.
He studied at Medical School at the University of Patra, Greece and received his MD degree in 2009. Afterwards he started his residency in Medical Oncology at the University Hospital of Gothenburg in Sweden.
As a Consultant in Medical Oncology he has a special interest in breast cancer and cancers of gastrointestinal tract.
Education/ Academic Experience
29/07/2009 Medical Doctor, University of Patras, School of Medicine, Patras, Greece
2000 – 2003 Education in Pharmaceutical Sciences, University of Patras, Department of Pharmacy, Patras, Greece
Professional Experience
04/2019 – present: Consultant in Medical Oncology, German Medical Institute, Limassol, Cyprus
12/2018 – 03/2019: Specialist Doctor in Medical Oncology Department of Oncology, Nicosia General Hospital, Cyprus
02/2017 – 09/2018: Specialist Doctor in Oncology, Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden
08/2012 – 01/2017: Resident Doctor in Clinical Oncology Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden
05/2010 – 05/2012: Resident Doctor in Internal Medicine Department of Internal Medicine, Norra Älvsborgs Hospital, Trollhättan, Sweden
Certifications & Courses
Swedish Association of Oncology: Member of the board 2014-2017
Ung Cancer: Member of the board 09/2014-05/2015
Medical Acute Life Support (Medical ALS) 2012
Publications
A.Papadopoulos, A. Balta, J. Björkqvist, F. Baghaei, U.Stierner: Case Report: Diffuse melanosis in malignant melanoma with bone marrow involvement and APTT prolongation without bleeding manifestations. 2015 Annual Meeting / Swedish Association of Oncology, Umeå, Sweden, 16 – 20 Mars 2015.
Papadopoulos, J. Kindblom: Gastrointestinal Stromal Tumors (GIST): A review of 31 patients from Sahlgrenska University Hospital. 2017 Annual Meeting / Swedish Association of Oncology, Örebro, Sweden, 20-24 Mars 2017
Professional Memberships
Member of the American Society of Clinical Oncology (ASCO) 2015-2016